ClinVar Miner

Submissions for variant NM_206933.3(USH2A):c.1679del (p.Pro560fs) (rs773539640)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000668895 SCV000793569 pathogenic Usher syndrome, type 2A; Retinitis pigmentosa 39 2017-08-18 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000414082 SCV000339397 pathogenic not provided 2016-02-17 criteria provided, single submitter clinical testing
GeneDx RCV000414082 SCV000490869 pathogenic not provided 2015-04-23 criteria provided, single submitter clinical testing The c.1679delC variant in the USH2A gene has been reported in association with Usher syndrome type 2A (Weston et al., 2000). The deletion causes a frameshift starting with codon Proline 560, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 31 of the new reading frame, denoted p.Pro560LeufsX31. The c.1679delC variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Therefore, we interpret this variant as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.